1
Return

Effects of Curcumin/Turmeric Supplementation on Lipid Profile in Subjects With Prediabetes and Diabetes: A Systematic Review and Meta-Analysis

delete2026-02-01
delete0
PRE
AI
H
Hossein Bahari *
M
MalekAhmadi, Mahsa
M
Mostafa Shahraki Jazinaki
Z
Zahra Asadi
K
Kimia Soltaninejad
H
Haniyeh Golafrouz
DOI:10.1002/lipd.70037delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Dyslipidemia is a key comorbidity in prediabetes and type 2 diabetes (T2D). Curcumin, from turmeric, may improve lipid levels, but evidence is inconsistent. This meta-analysis evaluates its efficacy on lipid profiles in this population. We searched PubMed, Web of Science, and Scopus until August 2025 for RCTs on curcumin/turmeric in adults with prediabetes/T2DM. Data on lipids (triglycerides, total cholesterol, LDL-C, HDL-C) were pooled using a random-effects model, expressed as weighted mean differences (WMD) with 95% confidence intervals (CIs). Twenty-seven RCTs (31 arms) were included. Curcumin/turmeric supplementation significantly reduced triglycerides (WMD: -13.73 mg/dL; 95% CI: -19.49, -7.96), total cholesterol (WMD: -5.24 mg/dL; 95% CI: -9.42, -1.07), and LDL-C (WMD: -5.72 mg/dL; 95% CI: -8.62, -2.82) and increased HDL-C (WMD: 2.14 mg/dL; 95% CI: 1.08, 3.20). Effects on apolipoproteins were non-significant. Significant heterogeneity was observed (I-2 > 80%). Subgroup analyses indicated greater benefits in diabetic patients, those with higher baseline lipids, and with specific formulations. The certainty of evidence (GRADE) was low for all outcomes. Curcumin/turmeric supplementation yields modest improvements in the lipid profile of individuals with prediabetes and diabetes. However, significant heterogeneity and low certainty of evidence limit the robustness and clinical applicability of these findings. Therefore, the results should be interpreted with caution. Future trials should prioritize enhanced formulations and longer durations.
Keywords:
curcumin
diabetes
lipids
meta-analysis
prediabetes
turmeric

Journal

L
LIPIDS
IF:
1.6
Papers:
48
Citations:
0

Organization

S
Shiraz University of Medical Science
Scholars:
9.4K
Papers: 5.4K
Citations: 15
I
iran university of medical sciences
Scholars:
1.5K
Papers: 665
Citations: 0
T
tehran university of medical sciences
Scholars:
2.9W
Papers: 1.8W
Citations: 30
M
Mashhad University of Medical Sciences
Scholars:
1.1W
Papers: 6.5K
Citations: 7.6K
Cited Papers

Cited Papers

Citing Papers

Citing Papers